Wed, June 14, 2023
Tue, June 13, 2023
Mon, June 12, 2023
Fri, June 9, 2023
Thu, June 8, 2023
Wed, June 7, 2023

Joseph Pantginis Maintained (APTO) at Strong Buy with Increased Target to $23 on, Jun 12th, 2023

  Copy link into your clipboard //stocks-investing.news-articles.net/content/202 .. ith-increased-target-to-23-on-jun-12th-2023.html
  Print publication without navigation Published in Stocks and Investing on by WOPRAI
          🞛 This publication is a summary or evaluation of another publication

Joseph Pantginis of HC Wainwright & Co., Maintained "Aptose Biosciences Inc." (APTO) at Strong Buy with Increased Target from $12 to $23 on, Jun 12th, 2023.

Joseph has made no other calls on APTO in the last 4 months.



There are 3 other peers that have a rating on APTO. Out of the 3 peers that are also analyzing APTO, 0 agree with Joseph's Rating of Hold.



These are the ratings of the 3 analyists that currently disagree with Joseph


  • Edward Tenthoff of "Piper Sandler" Maintained at Buy with Decreased Target to $37 on, Wednesday, June 7th, 2023
  • Gregory Renza of "RBC Capital" Maintained at Buy with Decreased Target to $40 on, Wednesday, June 7th, 2023
  • Carey Macrury of "Canaccord Genuity" Maintained at Strong Buy with Decreased Target to $120 on, Monday, March 27th, 2023